Skip to main content

Point-of-Care Coagulation Management in Intensive Care Medicine

  • Chapter
Annual Update in Intensive Care and Emergency Medicine 2013

Abstract

Coagulopathy in critically ill patients is common and of multifactorial origin [1]. Coagulopathy-associated risk of bleeding and the use of allogeneic blood products are independent risk factors for morbidity and mortality [2, 3]. Therefore, prompt and correct identification of the underlying causes of these coagulation abnormalities is required, since each coagulation abnormality necessitates very different therapeutic management strategies. Standard laboratory tests of blood coagulation yield only partial diagnostic information, and important coagulation defects, e.g., reduced clot stability, platelet dysfunction, or hyperfibrinolysis, remain undetected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10:222

    Article  PubMed  Google Scholar 

  2. Glance LG, Dick AW, Mukamel DB, et al (2011) Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 114:283–292

    Article  PubMed  Google Scholar 

  3. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116:2544–2552

    Article  PubMed  Google Scholar 

  4. Gorlinger K, Bergmann L, Dirkmann D (2012) Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 26:179–198

    Article  PubMed  Google Scholar 

  5. Kozek-Langenecker S (2007) Management of massive operative blood loss. Minerva Anestesiol 73:401–415

    PubMed  CAS  Google Scholar 

  6. Haas T, Spielmann N, Mauch J, et al (2012) Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 108:36–41

    Article  PubMed  CAS  Google Scholar 

  7. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM (2009) Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 101:394–401

    PubMed  CAS  Google Scholar 

  8. Jambor C, von Pape KW, Spannagl M, Dietrich W, Giebl A, Weisser H (2011) Multiple electrode whole blood aggregometry, PFA-100, and in vivo bleeding time for the point-of-care assessment of aspirin-induced platelet dysfunction in the preoperative setting. Anesth Analg 113:31–39

    Article  PubMed  CAS  Google Scholar 

  9. Hartert H (1951) Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 117:189–203

    Article  PubMed  CAS  Google Scholar 

  10. Avidan MS, Alcock EL, Da Fonseca J, et al (2004) Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92:178–186

    Article  PubMed  CAS  Google Scholar 

  11. Ak K, Isbir CS, Tetik S, et al (2009) Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 24:404–410

    Article  PubMed  Google Scholar 

  12. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF (2009) Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 18:277–288

    Article  PubMed  Google Scholar 

  13. Weber CF, Gorlinger K, Meininger D et al (2012) Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:531–547

    Article  PubMed  Google Scholar 

  14. Nuttall GA, Oliver WC, Santrach PJ et al (2001) Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94:773–781

    Article  PubMed  CAS  Google Scholar 

  15. Gorlinger K, Dirkmann D, Hanke AA et al (2011) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115:1179–1191

    PubMed  Google Scholar 

  16. Wang SC, Shieh JF, Chang KY et al (2010) Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 42:2590–2593

    Article  PubMed  Google Scholar 

  17. Gorlinger K (2006) Coagulation management during liver transplantation. Hamostaseologie 26:S64–S76

    PubMed  CAS  Google Scholar 

  18. Gorlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schochl H (2012) Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 39:104–113

    Article  PubMed  Google Scholar 

  19. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ (2006) Guidelines on the management of massive blood loss. Br J Haematol 135:634–641

    Article  PubMed  CAS  Google Scholar 

  20. Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH (2008) Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 36:1114–1118

    Article  PubMed  Google Scholar 

  21. Watson GA, Sperry JL, Rosengart MR et al (2009) Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 67:221–227

    Article  PubMed  Google Scholar 

  22. Maegele M, Lefering R, Yucel N et al (2007) Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 38:298–304

    Article  PubMed  Google Scholar 

  23. Rourke C, Curry N, Khan S et al (2012) Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 10:1342–1351

    Article  PubMed  CAS  Google Scholar 

  24. Holcomb JB, Minei KM, Scerbo ML et al (2012) Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 256:476–486

    Article  PubMed  Google Scholar 

  25. Schochl H, Nienaber U, Hofer G et al (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55

    Article  PubMed  Google Scholar 

  26. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J (2011) Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev CD007871

    Google Scholar 

  27. Adamzik M, Eggmann M, Frey UH et al (2010) Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 14:R178

    Article  PubMed  Google Scholar 

  28. Adamzik M, Langemeier T, Frey UH et al (2011) Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock 35:339–342

    Article  PubMed  Google Scholar 

  29. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM). Eur J Cardiothorac Surg 31:1052–1057

    Article  PubMed  Google Scholar 

  30. Crowther MA, Warkentin TE (2008) Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 111:4871–4879

    Article  PubMed  CAS  Google Scholar 

  31. Hiippala ST, Myllyla GJ, Vahtera EM (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–365

    PubMed  CAS  Google Scholar 

  32. Bolliger D, Gorlinger K, Tanaka KA (2010) Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 113:1205–1219

    Article  PubMed  Google Scholar 

  33. Warmuth M, Mad P, Wild C (2012) Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 56:539–548

    Article  PubMed  CAS  Google Scholar 

  34. Dickneite G, Pragst I (2009) Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 102:345–354

    Article  PubMed  CAS  Google Scholar 

  35. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA (2006) The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg 102:1280–1284

    Article  PubMed  Google Scholar 

  36. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR (1991) Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 75:563–570

    Article  PubMed  CAS  Google Scholar 

  37. Picker SM (2011) vitro assessment of platelet function. Transfus Apher Sci 44:305–319

    Article  PubMed  Google Scholar 

  38. Lethagen S (1994) Desmopressin (DDAVP) and hemostasis. Ann Hematol 69:173–180

    Article  PubMed  CAS  Google Scholar 

  39. Cauwenberghs S, van Pampus E, Curvers J, Akkerman JW, Heemskerk JW (2007) Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 21:287–294

    Article  PubMed  Google Scholar 

  40. Korte W (2010) F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 24:85–93

    Article  PubMed  CAS  Google Scholar 

  41. Yank V, Tuohy CV, Logan AC et al (2011) Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 154:529–540

    PubMed  Google Scholar 

  42. Shander A, Van Aken H, Colomina MJ et al (2012) Patient blood management in Europe. Br J Anaesth 109:55–68

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Zacharowski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg and BioMed Central Ltd.

About this chapter

Cite this chapter

Meybohm, P., Zacharowski, K., Weber, C.F. (2013). Point-of-Care Coagulation Management in Intensive Care Medicine. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2013. Annual Update in Intensive Care and Emergency Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35109-9_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35109-9_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35108-2

  • Online ISBN: 978-3-642-35109-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics